JBJ-04-125-02
Product Specifications
CAS Number
2060610-53-7
Target
JAK, EGFR
Related Pathways
JAK/STAT signaling, Angiogenesis, Stem Cells, Chromatin/Epigenetic, Tyrosine Kinase/Adaptors
Bioactivity
JBJ-04-125-02 can inhibit cancer cell proliferation and EGFRL858R/T790M/C797S signaling. JBJ-04-125-02 has anti-tumor activities. JBJ-04-125-02 is a potent, mutant-selective, allosteric and orally active EGFR inhibitor with an IC50 of 0.26 nM for EGFRL858R/T790M.
Smiles
[C@@H](C(NC1=NC=CS1)=O)(N2C(=O)C=3C(C2)=CC=C(C3)C4=CC=C(C=C4)N5CCNCC5)C6=C(O)C=CC(F)=C6
Molecular Formula
C29H26FN5O3S
Molecular Weight
543.61
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
129549-APC 100 µL
MED6 (ARC33, Mediator of RNA Polymerase II Transcription Subunit 6, Activator-recruited Cofactor 33kD Component, Mediator Complex Subunit 6, Renal Carcinoma Antigen NY-REN-28) (APC)
Sign In for Pricing
View Details bsm-62071R-RBITC-TR 20 µL
NHEJ1 Recombinant Antibody, RBITC Conjugated
Sign In for Pricing
View Details